{
  "id": 11513528,
  "title": "Computer-designed protein targets immune receptor linked to inflammation at new 'undruggable' site",
  "url": "https://urgent.news/2026/10/02/computer-designed-protein-targets-immune-receptor-linked-to",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-02T19:40:01.000Z",
  "source": {
    "name": "Phys.org",
    "slug": "phys-org",
    "url": "https://phys.org/news/2026-10-protein-immune-receptor-linked-inflammation.html"
  },
  "original_language": "en",
  "account": "A new study from Scripps Research has engineered a synthetic protein that targets an undruggable site on the Toll-like receptor 4 (TLR4) immune receptor, blocking inflammatory responses. TLR4, an essential immune receptor, has been linked to inflammatory disorders when overactive. No FDA-approved drugs specifically block TLR4, making it a challenging target for therapies. The research team at Scripps Research discovered that the membrane-spanning region of TLR4, previously thought to passively attach it to the cell membrane, plays an active role in determining inflammatory responses. By designing a synthetic protein that binds more effectively within this region, the team aimed to reduce TLR4-initiated inflammation. They used computer programs to generate 3D protein structures, optimizing them for apolar packing within the greasy cell membrane. The resulting synthetic protein, Design-6, showed significant potential in reducing NF-κB inflammatory signaling when tested in human cell cultures. This breakthrough opens up new possibilities for developing anti-inflammatory treatments targeting previously inaccessible regions of TLR4.",
  "summary": "To sense their environment and respond accordingly, cells enlist membrane proteins as communication hubs, receiving molecular messages from outside and triggering responses inside. One of these proteins is Toll-like receptor 4 (TLR4), an immune receptor that plays an essential role in protecting against infections. But overactivity of TLR4 has been linked to inflammatory disorders like sepsis,…",
  "key_points": [
    "Scripps Research engineers synthetic protein targeting undruggable TLR4 site",
    "Design-6 protein reduces NF-κB inflammatory signaling in human cell cultures",
    "TLR4 linked to inflammatory disorders with no current FDA-approved blocking drugs"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}